Cyclins and breast cancer

Breast Cancer Research and Treatment

Volumn 52, Issue 1-3, 1998, Pages 17-28

  Steeg, Patricia S ^a   Zhou, Qun ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cyclin D; Cyclin E; DCIS; Prevention; Tumor progression

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN E; CYCLINE; ESTROGEN RECEPTOR; GOSSYPOL; RETINOID; TAMOXIFEN;

BREAST CANCER; BREAST DUCT; CANCER PREVENTION; CARCINOMA IN SITU; CELL CYCLE; CELL CYCLE G1 PHASE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSACTIVATION; TRANSGENIC MOUSE;

EID: 0032443066     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006102916060     Document Type: Review

References (80)

1. Sherr C: Cancer cell cycles. Science 274:1672-1677, 1996
2. Gao C, Zelenka P: Cyclins, cyclin-dependent kinases and differentiation. Bioessays 19:307-315, 1997
3. Tlsty T: Genomic instability and its role in neoplasia. Curr Top Microbiol 221:37-46, 1997
4. Sarcevic B, Lilischkis R, Sutherland R: Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E- and A-type cyclin-CDK complexes. J Biol Chem 272:33327-33337, 1997
5. Hunter T, Pines J: Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79:573-582, 1994
6. Zwijsen R, Wientjens E, Klompmaker R, van der Smart J, Bernards R, Michalides R: CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405-415, 1997
7. Neuman E, Ladha M, Lin N, Upton T, Miller S, Renzo JD, Pestell R, Hinds P, Dowdy S, Brown M, Ewen M: Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 17:5338-5347, 1997
8. Asano K, Sakamoto H, Sasaki H, Ochiya T: Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells. Biochem Biophys Res Commun 217:1169-1176, 1995
9. Zhou P, Jiang W, Weghorst CM, Weinstein IB: Overexpression of cyclin D1 enhances gene amplification. Cancer Res 56:36-39, 1996
10. Pagano M, Theodoras AM, Tam SW, Draetta GF: Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Devel 8:1627-1639, 1994
11. Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514, 1992
12. Lahti J, Li H, Kidd V: Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1. J Biol Chem 272:10859-10869, 1997
13. Freeman R, Estus S, Johnson EM Jr: Analysis of cell cycle-related gene expression in postmitotic neurons: Selective induction of cyclin D1 during programmed cell death. Neuron 12:343-355, 1994
14. Kranenburg O, van der Eb AJ, Zantema A: Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J 15:46-54, 1996
15. Wang T, Cardiff R, Zukerberg L, Lees E, Arnold A, Schmidt E: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669-671, 1994
16. Sicinski P, Donaher J, Parker S, Li T, Fazeli A, Gardner H, Haslam S, Bronson R, Elledge S, Weinberg R: Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630, 1995
17. Fantl V, Stamp G, Andrews A, Roswell I, Dickson C: Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Devel 9:2364-2372, 1995
18. Resnitzky D, Gossen M, Bujard H, Reed S: Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14:1669-1679, 1994
19. Quelle D, Ashmun R, Shurtleff S, Kato J-Y, Bar-Sagi D, Roussel M, Scherr C: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Devel 7:1559-1571, 1993
20. Hiyama H, Iavarone A, LaBaer J, Reeves S: Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene 14:2533-2542, 1997
21. Jiang W, Kahn SM, Zhou P, Zhang Y, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB: Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8:3447-3457, 1993
22. Atadja P, Wong H, Veilete C, Riabowol K: Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp Cell Res 217:205-216, 1995
23. Lovec H, Sewing A, Lucibello FC, Muller R, Moroy T: Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 9:323-326, 1994
24. Musgrove E, Lee C, Buckley M, Sutherland R: Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci USA 91:8022-8026, 1994
25. Musgrove E, Sarcevic B, Sutherland R: Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for cdk2 activation and pRB hyperphosphorylation. J Cell Biochem 60:363-378, 1996
26. Wilcken N, Prall O, Musgrove E, Sutherland R: Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth inhibitory effects of antiestrogens. Clin Cancer Res 3:849-854, 1997
27. Zwijsen RM, Klompmaker R, Wientjens EB, Kristel PM, van der Burg B, Michalides RJ: Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol Cell Biol 16:2554-2560, 1996
28. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J: Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57:353-361, 1994
29. Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9:707-718, 1994
30. Lukas J, Bartkova J, Bartek J: Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol Cell Biol 16:6917-6925, 1996
31. Han EK-H, Sgambato A, Jiang W, Zhang Y-J, Santella R, Doki Y, Cacace A, Schieren I, Weinstein IB: Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 10:953-961, 1995
32. Han E-H, Begemann M, Sgambato A, Soh J-W, Doki Y, Xing W-Q, Liu W, Weinstein IB: Increased expression of cyclin D1 in a murine mammary epithelial celt line induces p27kip1, inhibits growth and enhances apoptosis. Cell Growth Diff 7:699-710, 1996
33. Barnes D: Cyclin D1 in mammary carcinoma. J Pathol 181:267-269, 1997
34. Hui R, Campbell D, Lee C, McCaul K, Horsfall D, Musgrove E, Daly R, Seshadri R, Sutherland R: EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenoytpes in primary breast cancer. Oncogene 15:1617-1623, 1997
35. Zuckerberg L, Yang W, Gadd M, Thor A, Koerner F, Schmidt E, Arnold A: Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol 8:560-567, 1995
36. Michalides R, Hageman P, van Tinteren H, Houben L, Wientjens E, Klompmaker R, Peterse J: A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 73:728-734, 1996
37. Barbareschi M, Pelosio P, Caffo O, Buttitta F, Pellegrini S, Barbazza R, Dalla Palma P, Bevilacqua G, Marchetti A: Cyclin D1-gene amplification and expression in breast carcinoma: Relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21waf immunohistochemical expression. Int J Cancer 74:171-174, 1997
38. D'Urso C, Marracino R, Marshak D, Roberts J: Cell cycle control of DNA replication by a homologue from human cells of the p34cdc2 protein kinase. Science 250:786-791, 1990
39. Koff A, Giordano A, Desai D, Yamashita K, Harper J, Elledge S, Nishimoto T, Morgan D, Framza B, Roberts J: Formation and activation of a cyclin Ecdk2 complex during the G1 phase of the human cell cycle. Science 257:1689-1694, 1992
40. Elledge S, Harper J: Cdk inhibitors: on the threshold of checkpoints and development. Curr Opin Cell Biol 6:847-852, 1994
41. Hunter T: Breaking the cycle. Cell 75:839-841, 1995
42. Sherr C, Roberts J: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Devel 9:1149-1163, 1995
43. Li Y, Graham C, Lacy S, Duncan A, Whyte P: The adenovirus E1A associated 130 KD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Devel 7:2366-2377, 1993
44. Weinberg R: The retinoblastoma protein and cell cycle control. Cell 81:323-330, 1995
45. Ohtsubo M, Theodoras A, Schumacher J, Roberts J, Pagano M: Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15:2612-2624, 1995
46. Ohtsubo M, Roberts J: Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908-1912, 1993
47. Bortner D, Rosenberg M: Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 17:453-459, 1997
48. Resnitzky D, Reed S: Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol Cell Biol 15:3463-3469, 1995
49. Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J: Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol Cell Biol 15:2600-2611, 1995
50. Beijersbergen R, Carlee L, Kerhovn R, Bernards R: Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Devel 9:1340-1353, 1995
51. Keyomarsi K, Pardee A: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90:1112-1116, 1993
52. Courjal F, Louason G, Speiser P, Katasaros D, Zeillinger R, Theillet C: Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int J Cancer 69:247-253, 1996
53. Gray-Bablin J, Zalvide J, Fox M, Knickerbocker C, DeCaprio J, Keyomarsi K: Cyclin E, a redundant cyclin in breast cancer. Proc Natl Acad Sci USA 93: 15215-15220, 1996
54. Sewing A, Ronicke Y, Burger C, Funk M, Muller R: Alternative splicing of cyclin E. J Cell Sci 107:581-588, 1994
55. Keyomarsi K, Conte D Jr, Toyofuku W, Fox MP: Deregulation of cyclin E in breast cancer. Oncogene 11:941-950, 1995
56. Won K-A, Reed S: Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J 15:4182-4193, 1996
57. Sgambato A, Doki Y, Schieren I, Weinstein IB: Effects of cyclin E overexpression on cell growth and response to transforming growth factor β depend on cell context and p27kip1 expression. Cell Growth Diff 8:393-405, 1997
58. Nielsen N, Arnerlov C, Emdin S, Landberg H: Cyclin E overexpression, a negative prognostic factor in breast cancer with a strong correlation to oestrogen receptor status. Br J Cancer 74:874-880, 1996
59. Porter P, Malone K, Heagerty P, Alexander G, Gatti L, Firpo E, Daling J, Roberts J: Expression of cell cycle regulators p27kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med 3:222-225, 1997
60. Scott K, Walker R: Lack of cyclin E immunoreactivity in non-malignant breast and association with proliferation in breast cancer. Br J Cancer 76:1288-1292, 1997
61. Nielsen N, Emdin S, Cajander J, Landberg G: Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Br J Cancer 76:295-304, 1997
62. Page D, DuPont W: Anatomic indicators (histologic and cytologic) of increased breast cancer risk. Breast Cancer Res Treat 28:157-166, 1993
63. Page D, DuPont W: Anatomic markers of human premalignancy and risk of breast cancer. Cancer 66:1326-1335, 1990
64. DuPont W, Page D: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146-151, 1985
65. Weinstat-Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL, Steeg PS: Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med 1:1257-1260, 1995
66. Steeg PS, Clare SE, Lawrence JA, Zhou Q: Molecular analysis of premalignant and carcinoma in situ lesions of the human breast. Am J Pathol 149:733-738, 1996
67. Simpson J, Quan D, O'Malley F, Odom-Maryon T, Clarke P: Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am J Pathol 151:161-168, 1997
68. Gillett C, Lee A, Millis R, Barnes D: Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. J Pathol 184:396-400, 1998
69. Stanta G, Bonin S, Losa L, Eusebi V: Molecular characterization of intraductal breast carcinomas. Virchows Arch 432:107-111, 1998
70. Zhou Q, Stetler-Stevenson M, Steeg P: Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro. Oncogene 15:107-115, 1997
71. Rubin M, Fenig E, Rosenauer A, Menendez-Botet C, Achkar C, Bentel JM, Yahalom J, Mendelsohn J, Miller WH: 9-cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res 54:6549-6556, 1994
72. Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B, Fontana JA: p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11:493-504, 1995
73. Lotan R: Retinoids in cancer chemoprevention. FASEB J 10:1031-1039, 1996
74. Zhao ZM, Sheikh MS, Rishi AK, Dawson MI, Li XS, Wilber JF, Feng P, Fontana JA: Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells. Expt Cell Res 219:555-561, 1995
75. Anzano MA, Byers SW, Smith JM, Peer CW, Mullen LT, Brown CC, Roberts AB, Sporn MB: Prevention of breast cancer in the rat with 9-cis-retinoic acid as single agent and in combination with tamoxifen. Cancer Res 54:4614-4617, 1994
76. Zhu W-Y, Jones C, Kiss A, Matsukuma K, Amin S, DeLuca L: Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells. Exp Cell Res 234:293-299, 1997
77. Wilcken N, Sarcevid B, Musgrove E, Sutherland R: Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells. Cell Growth Diff 7:65-74, 1996
78. Teixeira C, Pratt M: CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells. Mol Endocrinol 11:1191-1202, 1997
79. Seewaldt V, Kim J-H, Caldwell L, Johnson B, Swisshelm K, Collins S: All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells. Cell Growth Diff 8:631-641, 1997
80. Ligueros M, Jeoung D, Tang B, Hochhauser D, Reidenberg M, Sonenberg M: Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells. Br J Cancer 76:21-28, 1997